Sanguine Resources

News | Events | Case Studies | Spotlight

Accessing Patients with In-Home Biospecimen Collection

With more than 40,000 ongoing global clinical trials, COVID-19 will cause immense delays with the advancement of research. For non-invasive biospecimen studies and clinical trials that require test subjects to visit hospitals or clinics for biospecimen collection, will the patients just stop showing up for collection?